Prevnar 13 34 mcg (Corynebacterium Diphtheriae Crm-197 Protein) Suspension

PREVNAR 13 34 MCG is a vaccine designed to protect against pneumococcal diseases. This suspension is administered intramuscularly and is manufactured by Pfizer Canada ULC.

PREVNAR 13 34 MCG is used to prevent infections caused by the Streptococcus pneumoniae bacteria. It is commonly administered to infants and children to protect against pneumococcal diseases, including pneumonia, meningitis, and bloodstream infections. The vaccine works by stimulating the body's immune system to produce antibodies against the bacteria, providing long-term protection.

Common effects of PREVNAR 13 34 MCG may include redness, swelling, or pain at the injection site. Some individuals may experience mild fever, fatigue, or irritability following vaccination. These effects are generally mild and temporary, resolving within a few days.

PREVNAR 13 34 MCG should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to inform the healthcare provider about any current illnesses or allergies before receiving the vaccine.

PREVNAR 13 34 MCG may interact with other medications or vaccines. It is advisable to discuss all current medications with a healthcare provider before receiving the vaccine. Additionally, individuals should avoid taking other vaccines simultaneously unless advised by a healthcare professional.